Combinatorial Approaches Towards Identification of Host Microbe Interactions for Enteric Disorders Linked to Reactive Arthritis

Abstract

Reactive Arthritis (ReA), a sporadic rheumatic autoimmune disorder falls under the category of seronegative inflammatory arthritis (seronegative spondyloarthropathies (SpA)) along with Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA). It is triggered due to enteric and urogenital infections via reported microorganisms such as Salmonella, Shigella, Yersinia, Campylobacter, Chlamydia and others. ReA along with AS and PsA show similar features such as sacroilitis, spondylitis, arthritis and bone changes during the initial disease stages and are thus difficult to be demarcated. Though, proximate classification criteria for early diagnosis of AS and PsA exist, their differentiation from ReA is a challenging task due to the presence of non-standardised diagnostic and classification criteria for ReA. A multi-disciplinary approach in our study to find vital drug targets and biomarkers for understanding the etiopathological and prognostic features along with explicit diagnostic and therapeutic regimen of this uncharted disorder. We utilized a combinatorial approach that amalgamates in-depth in-silico work-pipeline and experimental validation techniques to substantiate the findings. In-silico systems biology analysis includes techniques such as text mining, metabolic network reconstruction, simulation, filtering and network assessments. Vital human markers and targets obtained through in-silico analysis for IBD allied ReA are cross-validated through targeted gene expression experimental analysis following non-probabilistic convenience sampling in ReA patients. Our study provides insights into factors and processes comprehending host-microbe cross-talk and asserts the missing links in understanding the biological functions, clinico-molecular informatics-based indications, host-microbe and microbe-microbe interspecies communications in infection elicited seronegative rheumatic autoimmunity and inflammatory disorders, here as in IBD affiliated ReA by retrieving drug targets, biomarkers, pathways and inhibitor.

Description

Keywords

Citation

item.page.endorsement

item.page.review

item.page.supplemented

item.page.referenced